Sc , namely, protein misfolding cyclic amplification, conformation-dependent immunoassay, dissociation-enhanced lanthanide fluorescent immunoassay, capillary gel electrophoresis, fluorescence correlation spectroscopy, flow microbead immunoassay, etc. Additionally, functionally relevant prion-susceptible cell culture models that recognize the complexity of the mechanisms of prion infection have also been pursued, not only in relation to diagnosis, but also in relation to prion biology. Prion protein (PrP) gene-deficient neuronal cell lines that can clearly elucidate PrP C functions would contribute to understanding of the prion infection mechanism. In this review, we describe the trend in recent development of diagnostic methods and cell culture models for prion diseases and their potential applications in prion biology.
Evidence of prion infections has been established by the accumulation of an abnormal isoform of prion protein (PrP Sc ) and/or infectivity after multiple passages [54, 85, 94, 131] . In vitro conversion of the cellular isoform of prion protein (PrP C ) to form PrP Sc -like products has been demonstrated by incubating 35 S-labeled PrP C with PrP
Sc
. This produced a protease-resistant radioactive product with the mobility of protease-treated authentic PrP Sc [55] . This in vitro conversion confirms the species- [90] and strain-specificities [7] observed in vivo. However, because the yield is less stoichiometric than for PrP Sc [55] , it has not been possible to determine whether or not an increase in infectivity occurred [55] . Recent progress in the development of diagnostic methods for PrP Sc detection has dramatically facilitated many approaches in prion biology. The protein misfolding cyclic amplification (PMCA) method deserves special mention [96] . Hitherto, it has not been possible to renature completely denatured prion preparations to an infectious state [79, 81] ; however, the novel PMCA approach enables in vitro amplification of infectious prions [16] .
The susceptibility of cell lines, such as N2a, in an in vitro cell culture assay to prion infections has been assessed by exposing the cells to serial dilutions of prion-infected mouse brain homogenates, and the dilution rate yielding negative outcome in a blotting assay for PrP Sc has been determined to be the infectivity level. Prion concentrations equivalent to those determined in an animal bioassay [9] have been quantitatively established using the same assay. The application spectrum of this prion cell assay for cell lineage can be extended from N2a to several other cell lines. Therefore, this greatly facilitates the mission of searching for prionsusceptible cell lines, and it is possible that this mission could be realized with the development of this assay and the recently innovated useful cell-culture models for prion infections. The present review introduces the recent advances in diagnostically useful methods and certain prion-susceptible cell lines that assist in understanding prion diseases.
PRP SC DISTRIBUTION IN TISSUES
Before venturing into designing diagnostic methods and prion-susceptible cells, the tissue distribution of PrP Sc in prion-infected animals should first be considered. Most of the diagnostic methods for prion infections depend on PrP Sc detection, while susceptibility of cells to prions, at least in part, depends on cell-type. Since PrP Sc tends to accumulate in the brains of prion-infected animals with neurons serving as the target, it is only natural that PrP Sc accumulations are selectively located in the neurons of both the central nervous system (CNS) and peripheral nervous system (PNS) [10, 32, 34, 62, 137] . However, certain combinations of prion strain and host species show PrP Sc accumulations in not only the CNS and PNS but also other tissues such as the tonsils, spleen, lymphnode, retina, proximal nerves, and gut-associ-ated lymphoid tissues [2, 12, 37, 39, 47, 89] . In the mouse, PrP Sc accumulates in the lymphoreticular systems (such as the spleen) in an infection route-independent manner before PrP Sc accumulation occurs in the brain, even if the mouse is intracerebrally inoculated [45] . PrP Sc was detected in onethird of skeletal muscle and spleen samples [32] as well as the olfactory epithelium in sporadic Creutzfeldt-Jakob disease (sCJD) patients [142] . In a study of scrapie-infected sheep, prion infectivity was observed in 80% of the affected animals with PrP Sc accumulation in the brain and PrP Sc was detected in placentae and lymph nodes [84] . It should be noted that PrP C is also highly expressed in the placentae of other species [123] . In fact, scrapie agents have been isolated from the placentae of sheep with natural scrapie [73] . Thus, the mother-offspring infection route may play an important role in natural transmission of scrapie.
PRP
SC IN BLOOD PrP Sc has been detected in blood in experimental mouse systems using the intracerebral (ic) and oral infection routes [17, 128] . PrP Sc initially accumulates in the follicular dendritic cells (FDCs) of the germinal centers in lymphoid tissues [53, 69] ; however, the biological event(s) that yields the presence of PrP Sc in blood remains unclear. Scrapie has been transmitted by experimental blood transfusions in sheep [44] . Furthermore, detectable levels of infectivity in the spleen and tonsils of two variant CJD (vCJD) patients have been measured with a bioassay that has been employed using ic-inoculation and RIII mice [13] . Although this same bioassay failed to detect infectivity in the buffy coat and plasma [13] , another study has demonstrated that mice infected with mouse-adapted vCJD or Gerstmann-Sträus-sler-Scheinker syndrome (GSS) harbor infectivity in the buffy coat and plasma [17] . Report of the possibility of blood borne transmission of vCJD in humans in the United Kingdom [61] has raised the need for a reliable prion detection method for clinical safety and may also contribute to development of a pre-mortem diagnosis method for prion diseases.
URINE PRP

SC
PrP
Sc has also been reported to exist in the urine of hamsters, cattle, and humans infected with prions [119] . However, urine PrP Sc may have certain features different from those of brain PrP Sc , as injections with the former do not cause prion disease [119] . Recently, several laboratories have reported that urine-derived PrP Sc comprises immunoglobulins or bacterial outer membrane proteins [29, 35, 118] . On the other hand, others have reported that urinary proteins from scrapie-infected mice with lymphocytic nephritis induced scrapie upon inoculation into noninfected indicator mice [117] . Therefore, infectivity associated with the absence and presence of PrP Sc in urine remains controversial. However, we do understand that certain proteins (urine PrP Sc , immunoglobulins, or bacterial outer membrane proteins) may serve as a biomarker of prion infection if they are specifically detected in prion-infected animals.
CONVENTIONAL DIAGNOSTIC METHODS FOR PRION DISEASES
Most of the methods used for diagnosis of prion infections (Table 1) rely on the presence of PrP Sc because the resistance of PrP Sc to PK digestion is the specific feature distinguishing PrP
Sc from PrP C [66, 67] . PrP C is completely degraded, whereas the C-terminal of fragment PrP Sc that remains after PK digestion can be detected by various method, such as Western blotting and enzyme-linked immunosorbent assay (ELISA). As PrP Sc is abundantly accumulated in the brain, brain samples are appropriate for these detection methods, which require post-mortem analysis. Immunohistochemical (IHC) examination of brain sections is a relatively reliable method of prion diagnosis [3, 46] in which typical features of prion diseases, such as accumulation of prion protein (PrP) amyloid plaques, astrogliosis, and neuronal cell loss, are examined by light microscopy. Vacuolation is also used as an index of prion infection. However, many combinations of prion strain and host species portray PrP Sc accumulation without vacuolation in brain sections after prion infection [48, 74] . Recently, positive diagnoses of PrP Sc accumulation in prion diseases have been established using histopathological analysis of organs/tissues other than the brain. The tonsils may be used in humans, deer, and sheep [38, 39, 112, 113, 130, 137, 140] , while the appendix has only been used for preclinical diagnosis of vCJD in humans [40, 41, 42, 47, 137] . Additionally, combination of the recently improved IHC analysis [using modified histoblot of paraffin-embedded tissue (PET) blot] with PK treatment or Western blotting has been introduced for detection of PrP Sc in cryosections and paraffin-embedded sections, respectively [92, 114, 124] .
Western blotting is a method used to detect PK-resistant PrP in extracts from the brain and other tissues. The mobility shift of bands for Western blotting provides information regarding the molecular weights of peptides. If the peptides are modified by aberrant glycosylation, different electrophoretic mobilities are observed. Therefore, electrophoretic mobility is influenced by host genotype and prion strain [75, 129] . In other words, the mobility index is often used for discriminating the CJD subtype [iatrogenic CJD (iCJD), sCJD, and vCJD], BSE, and scrapie strains [20, 36, 72, 77, 111, 136] .
Although the use of animal bioassays has hitherto been considered the most sensitive approach to detect prions, the recently developed Western blot test (see below) is currently considered to match or surpass bioassay reliability/accuracy [137] . Nevertheless, it remains unclear whether PrP Sc is completely identical in these cases or is the only entity of prions. Although PrP-expressing transgenic mice preinoculated with fibrils consisting of recombinant PrP have exhibited neuropathology similar to prion diseases [60] , detailed comparison analysis between these animals and prion-infected animals has yet to be attempted. Therefore, determination of infectivity with a reliable animal bioassay is the gold standard, although this assay may require a longer time period and many more animals. However, it should be noted that the volume of inoculum is critical for reducing the standard errors of the results in this animal bioassay. Characteristically, this assay can be complicated and may occasionally demand sophisticated techniques and effort [1] . Therefore, cell culture systems that specifically and reliably detect prions are urgently needed.
RECENTLY DEVELOPED DIAGNOSTIC TOOLS FOR PRION DISEASES
Recently, several modified Western blotting method have been developed for prion diagnosis. The cell blot [9, 24] and slot blot [141] assays have been further developed for detection of PrP Sc . Cell blot is a method that involves transferring cells grown on a coverslip to a nitrocellulose membrane and then PK-resistant PrP is detected by Western blotting [9] . Slot blot is a method in which cell lysates are filtered through a nitrocellulose membrane, slot blot membrane, and a slot-blot device before PK-resistant PrP is detected by Western blotting [141] . The sensitivity of Western blotting can be also enhanced by the extraction method, in which PrP Sc is precipitated with sodium phosphotungstic acid (PTA) [97, 137] . An efficient automated system with a detection limit of 10-pg could be established by combining PrP Sc extraction using guanidine hydrochloride with the time-resolved dissociation-enhanced fluoroimmunoassay (DELFIA) test [4, 22] . However, the PrP Sc concentration is no longer the parameter of this assay, but rather the percentage of insoluble PrP versus the total PrP content becomes the determinant index. Conformation-dependent immunoassay (CDI) is a method employed to detect conformational differences between PrP isoforms by measuring the relative antibody binding to denatured and native proteins [97] . CDI is used commercially for CDI testing at InPro Biotechnology, Inc. (U.S.A.). The flow microbead immunoassay (FMI) method, which uses anti-PrP antibody-coupled microbeads and a flow cytometer, was able to detect 7-pmol/7-nmol of recombinant PrP and PrP Sc spiked in bovine meat and bone meal at concentration higher than 0.3% [69] . It should be noted that Soto et al. have recently developed novel PMCA technology that cyclically amplifies the misfolding and aggregation process in vitro [122] . It is conceptually analogous to DNA amplification by polymerase chain reaction (PCR). The PMCA method amplifies PrP Sc and [16] . It is noteworthy that this approach is capable of prion detection in the blood of not only terminally diseased hamsters but also prion-infected presymptomatic hamsters [95] .
Capillary gel electrophoresis is an approach that takes advantage of the competitive antibody-binding between a fluorescein-labeled synthetic PrP peptide and PrP present in tissue samples [49, 109] ; free and antibody-peptide peaks are separated by capillary electrophoresis. Fluorescence correlation spectroscopy (FCS) is a method that detects individual fluorescence-labeled molecules in solutions [8, 31] . PrP Sc can be labeled by the anti-PrP antibody or by conjugation with labeled recombinant PrP.
Fourier transform infrared spectroscopy is a diagnostic method that incorporates multivariate analysis of infrared spectra to discriminate prion-infected animals from noninfected animals [110] . This type of spectroscopy-based approach is promising for ante-mortem diagnosis, as certain ray emissions, especially visible and near-infrared radiations, are transmittable through the animal body, thus facilitating materialization of non-invasive analysis [98, 101] . [91, 107, 138] . Interestingly, PrP Sc -specific binding aptamer inhibits the accumulation of protease-resistant forms of PrP in prionseeded in vitro conversion assay. Therefore, this type of aptamer subtype might not only serve as a diagnostic tool but might also facilitate therapeutic development and analytical use for investigation of prion diseases.
DETECTION TOOLS FOR PRPSC AND SURROGATE MARKERS FOR PRION DISEASES
PRION PERSISTENTLY INFECTED AND SUSCEPTI-BLE CELL LINES
Several prion-susceptible cell lines [9, 85] have been used for study of prion infection mechanisms ( Table 2 ). The general cell culture procedures for prion infection have been described previously [6] . Brain homogenates of prioninfected animals were added to culture media for 1 -2 days before culture passage. Infectivity or PrP Sc production per cell was assayed for percent infection of prions. Infectivity was measured after the brain samples of experimental animals were injected via ic inoculation. Harvested cells were lysed by repeating the freeze-thaw cycle before being injected into the brains of experimental animals. After performing behavioral observations for 1 year, the effective lethal dose (LD 50 ) was derived from the survival curve of the lysate-injected animals. PrP Sc detection in the cells and animals was usually performed by Western blotting.
The persistently infected cell line thus established was divided into the following 2 categories based on post-infection status: established after ex vivo or in vitro infection. In the former case, it has been established that immortalized cell groups are generated in prion-infected animals. Thus, primary cultures from prion-infected brains can easily provide cells with continuous passage, i.e., ScHB and SMB produced from prion-infected animals [19] . Several cell lines represent the examples of the latter case. For example, nerve growth factor (NGF)-differentiated PC12 cells can be infected with prions [94] , probably due to increased levels of PrP through NGF stimulation. Although derived from rat pheochromocytoma cells, PC12 cells are subject to infection by mouse-adapted scrapie. PC12 cell are the only cell line that defy the species barrier. Rabbit kidney-derived RK13 cells overexpressed with ovine PrP are susceptible to sheep scrapie infection [131] . Furthermore, mouse fibroblast NIH/3T3 and L929 cells are also susceptible to mouseadapted scrapie infection [135] . In other words, non-neuronal cells can also be infected with prions under certain conditions. It is consistent that PrP Sc is accumulated in not CJD: Creutzfeld-Jakob.
only the CNS but also the placenta, lymphoreticular systems (see above), and muscles [10, 127] . As the use of prion-susceptible cell line N2a is virtually simple for culture, this cell line is the most extensively employed for prion infection studies, although its low post-infection titers and rapid attenuation of titers require improvement [15, 85] . Neurohypothalamic cell line GT1 displays higher PrP C expression levels and is more susceptible to prion-infection than other cell lines [71, 108] . Although infection of human neuroblastoma cell line SH-SYS5 with CJD prions has been reported, reproducibility of this result has not been confirmed by other laboratories [58] . Therefore, cell culture systems for CJD and BSE prion infection have yet to be established.
USEFULLNESS OF CELL LINES FOR STUDYING PRION INFECTIONS
Transgenic mice have been used to analyze the specific amino acid residues and domains of PrP C for prion infection and PrP
Sc accumulation in organs/tissues [5, 18, 27, 28, 78, 116, 120, 126] . In sheep, the incidence of natural scrapie is associated with polymorphisms of the PrP gene (Prnp), particularly those at codons 136, 154, and 171 [23] , and arginine at position 171 in particular confers predominant resistance to scrapie [139] . Although the results obtained from these experiments provide important information on prion biology, the production of transgenic mice is timeconsuming and expensive. Therefore, this experimental approach is not practical for detailed analysis of PrP domains and amino acid residues, which requires use of many types of PrP mutant.
Cell culture models designed for study of prion infection facilitate better understanding of the molecular mechanisms of PrP Sc formation as well as the roles of the amino acid sequence and structural domains of PrP for conversion of PrP C to PrP Sc in a cell-autonomous fashion [43, 50, 132] . Hitherto, these types of studies, which have used persistently infected cell cultures [80, 93, 115] as de novo infections of cell cultures with prions, are restricted by a relatively low infection efficiency [86] . Cell lines susceptible to prions co-expressed with exogenous PrP are used for certain infection experiments [86, 108, 131, 135] ; however, interference of endogenous PrP by exogenous PrP in terms of the pathogenicity of prion agents from other species has also been reported [87, 88, 115, 125] . Moreover, concomitant expression of heterogenous PrP species seems to inhibit prion infection, even if cell lines expressing undetectable PrP levels (e.g., rabbit kidney epithelial RK13 cells) are used [131] . Therefore, Prnp -/-cell lines lacking endogenous PrP may serve as models for analysis of the real domain of PrP C required for prion pathogenicity without interfering with endogenous PrP by transfection of various deletion mutants of PrP following prion-infection [57] .
Although most cell lines and primary cells express PrP C [100] , only a limited few are susceptible to prion-infection. Moreover, it is intriguing that both neuronal and non-neuronal cell line are susceptible to prion infection [121] . PrP C appears to be not the sole determinant factor for prion susceptibility, and other cellular factors may be involved in efficient infections. Under certain conditions, loss of host factors for susceptibility to prion infection may occur [9, 54, 133] . Furthermore, most cell lines have restricted prion strain specificity, i.e., matching pairs between the host cell and prion strain. Recent development of human embryonic stem cells offers the promise of replacement of damaged adult cells with normal cells in regenerative medicine [25] , although the potential risk of infection of these cells with pathogens has been overlooked. Previously established cell lines, including human embryonic stem cell lines, should be examined to determine whether or not they have been contaminated with prions using sensitive diagnostic tests. Furthermore, we emphasize that research studies with newly created prion-susceptible human embryonic stem cell lines would contribute to elucidation of the infection mechanisms in prion-related diseases.
Finally, we would like to emphasize that the Prnp -/-cell line is reliable and useful for analysis of both PrP Sc accumulation and PrP C functions [59, 70, 102, [103] [104] [105] [106] . PrP C expression is required for prion infection [11, 14, 63, 83] , while after prion infection, PrP C -derived PrP Sc is accumulated in organs/tissues, especially in the brain. Although elucidation of the functions of PrP C is crucial in understanding the etiological mechanisms underlying prion diseases, these functions remain hitherto unclear in studies with Prnp -/-mice. In this review, we avoided redundant commentary on cell lines and PrP functions, as an extensive review has previously been documented [100] .
CONCLUSION Distribution of PrP
Sc depends on the prion strain and host species [52, 124] . Certain specific combinations of strain and host may lead to PrP Sc induction/distribution in the blood and urine. Therefore, development of a reliable method that facilitates PrP Sc detection in the blood and urine is urgently needed in terms of prion diagnosis and the safety of blood supplies in hospital wards.
Prion diseases can usually only be diagnosed by timeconsuming methods such as ELISA, Western blotting, immunohistochemical analysis, and animal bioassays [30] . Recently, dramatic improvement has been achieved for prion-sensitive diagnostic methods, although further development of analytical methods to specifically and reliably detect prions is even more important with increasing emphasis on reducing prion-related risks in terms of public health and the safety of blood supplies.
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